The goal of this symposium (available on demand) is to help clinicians understand both the utility and limitations of genetic testing in psychiatric practice. Our expert speakers, both researchers and clinicians, will share some of the scientific evidence for the role of pharmacogenomics in psychiatry.  They will review some of the most common genes associated with various psychiatric disorders.  They will also present practical pearls so you may learn how to use genetic testing to improve patient outcomes.

Who Should Attend this Symposium?

This symposium is ideal for the following professions:

• Psychiatrists
• Psychiatric & Mental Health Nurse Practitioners and Nurses
• Functional Medicine Physicians
• Integrative Medicine Physicians

What You’ll Learn

Learn from renowned experts in the field of genetic testing about important topics, including:

• The basics of psychiatric pharmacogenomics – pharmacokinetic, pharmacodynamic, and immunogenic genes
• How to interpret genotype and phenotype information in the context of medication
• The evidence base for clinically actionable gene-drug interactions
• The role of specific genes like MAO-A and COMT in disorders like ADHD, Anxiety, and Bipolar Disorder
• Using pharmacogenomics to address brain-gut axis dysfunction and psychiatric comorbidities
• The role of MTHFR and the dangers of both insufficient and excess folate in mental health disorders
• Practical, clinical application of pharmacogenomics with a review of multiple case studies

What is Psychiatry Redefined?

• An educational platform for practitioners who seek to move beyond symptom management or suppression and instead offer patients real recovery.
• A beacon of hope for individuals struggling with mental illness who are tired of ineffective treatments and ‘one size fits all’ interventions who seek personalized care.
• A bridge between discovery and application that infuses integrated therapeutic models with the very latest in scientific research.
• A vision brought to life for mental health professionals, patients, family members, and caregivers that focuses not only on neurologic health but also physical and emotional wellness. A functional roadmap integrating mind and body together in order to achieve balance and lasting health.
• A new model to move the field of psychiatry along a path illuminated by science.

Dr. Greenblatt, Founder

A pioneer in the field of integrative medicine, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School. Dr. Greenblatt currently serves as the Chief Medical Officer at Walden Behavioral Care in Waltham, MA and serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College Geisel School of Medicine.

An acknowledged integrative medicine expert, educator, and author, Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. Through three decades of practice and research, Dr. Greenblatt is a leading contributor to helping physicians and patients understand the role of personalized medicine for mental illness.

He is the author of seven books, including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD; Nutritional Lithium: A Cinderella Story; Answers to Anorexia; Integrative Medicine for Alzheimer’s; and Integrative Medicine for Binge Eating.

Dr. Greenblatt is the founder of Psychiatry Redefined, an educational platform dedicated to the transformation of psychiatry. Psychiatry Redefined offers online CME-approved courses, webinars, and fellowships for professionals to learn about functional and integrative medicine for mental illness. To learn more, please visit www.JamesGreenblattMD.com.